Remedy’s investor relations are coordinated by the Chief Executive Officer and Investor Relations Manager.

Investor meetings and statements issued by the company are subject to a silent period of 30 days preceding the publication of an interim report, half year report or a financial statements release.

Tero Virtala
Chief Executive Officer
+358 9 435 5040

Lauri Haavisto
Senior Manager, Investor & Talent Relations
+358 9 435 5040

General requests